Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cureus|March 6, 2023
Severe Lenalidomide-Associated HyperbilirubinemiaDaniel T Gildea, Joseph L RoswarskiBest Practice & Research. Clinical Haematology|December 13, 2023
Hodgkin lymphoma: Focus on evolving treatment paradigmsJoseph L Roswarski, Dan L LongoACG Case Reports Journal|April 1, 2026
Recurrent Immune Checkpoint Inhibitor Hepatitis With Pembrolizumab Cessation: A Stubborn Case of Delayed-Onset, Steroid-Refractory HepatotoxicityAllison Ladetto, Daniel T Gildea, Abhishek ShenoyHematological Oncology|June 19, 2026
Glofitamab Induces Complete Responses in Relapsed and Refractory Primary Central Nervous System LymphomaCoen J Lap, James Di Palma-Grisi, Andrew Ip, et al.Cureus|January 11, 2023
Bouveret Syndrome in a Cirrhotic PatientDaniel T Gildea, Dalal Alhaqqan, Krystina Johnson, et al.Cureus|January 10, 2022
When Recurring Infections Mask an Atypical Presentation of Inflammatory Bowel Disease (IBD): A Re-Visitation and Literature ReviewDaniel T Gildea, William Davis, Natalie Dapas, et al.Hepatic Medicine : Evidence and Research|February 28, 2023
COVID-19-Associated Liver InjuryDaniel T Gildea, Stephanie M Woo, Corinne E O'Connor, et al.Expert Review of Gastroenterology & Hepatology|July 15, 2022
Highlights of the drug-induced liver injury literature for 2021Stephanie M Woo, Dalal M Alhaqqan, Daniel T Gildea, et al.Pageof 1